Imago Biosciences

Developer of epigenetic-based therapies for rare genetic cancers

placeSan Francisco, California, United States calendar_todayFounded 2012 groups27 employees language imagobio.com

Registered entities

Social engagement

Social engagement: 2.7M social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Omega Funds, Blackstone, Farallon Capital Management; 3 have since exited.

Investor typeCountShare
Venture capital633%
Private equity317%
Accelerator & incubator16%
Bank & private debt16%
Other / undisclosed739%
Coming soon